You may have thought Botox® was used only for cosmetic procedures, but in 2004 the Food and Drug Administration (FDA) approved the same formulation (Botulinum Toxin Type A) for treatment of severe primary axillary hyperhidrosis (excessive underarm sweating) when antiperspirants fail. Botox neurotoxin treatment helps control excessive underarm sweating by temporarily blocking the chemical signals from the nerves that stimulate the sweat glands. When the sweat glands don’t receive chemical signals, the excessive sweating stops. Research has shown that treating the armpits, hands, feet, and face with botulinum toxin is safe and effective. In one clinical study involving 322 patients with severe underarm sweating, 81% of the patients receiving botulinum toxin injections achieved a greater than 50% reduction in sweating. And, 50% of the patients had their excessive sweating relieved for at least 201 days (nearly 7 months).
Unlike Botox for cosmetic purposes, Botox for treatment of hyperhidrosis is often covered by your insurance.